zika

Funding Alert: Contact Congress for Emergency Funding for Zika

Please contact Congress to urge the immediate passage of a bipartisan emergency supplemental bill for Zika.
Take Action

ASM Acts to Counter Zika Virus Outbreak

The emerging threat of Zika virus infection.
Read

ASM Urges Action to Combat Zika Emergency

Current events linked to the Zika virus make aggressive public health actions and funding to combat this emerging infectious disease more crucial than ever.
Read
Become a member today!
JOIN ASM
Submit Abstracts for Biothreats 2017
SUBMIT
Antibacterial Development Conference
REGISTER

buratowski steve

The Buratowski laboratory studies basic mechanisms of gene expression, more specifically the production of eukaryotic mRNA.  They use Saccharomyces cerevisiae as a model system, taking advantage of its amenability to both genetic and biochemical approaches.  The continue to characterize the initiation factors for RNA polymerase II (RNApII) and many recent projects relate to a series of phosphorylations that occur on the C-terminal domain (CTD) of the RNApII largest subunit.  The lab showed that the CTD phosphorylation pattern changes dramatically as the polymerase moves from 5' to 3' ends of a gene, essentially acting as a marker for the position of the polymerase.  These phosphorylations are used to recruit various mRNA processing and chromatin modifying complexes to specific regions of the gene as they are needed. For example, mRNA capping enzyme and the histone H3K4 methyltransferase Set1 are localized to regions near promoters, the H3K36 methyltransferase Set2 to middle regions, and polyadenylation factors to 3' ends.  The lab is exploring the function of the co-transcriptional histone methylations at H3K4 and H3K36, showing that these modifications recruit various histone deacetylases that help distinguish highly acetylated "real" promoters from cryptic promoters that occur by chance within transcribed regions.  Finally, they are working to understand the mechanisms by which RNApII transcription is terminated.  There are at least two distinct mechanisms: the classic cleavage/polyadenylation/torpedo mechanism that acts at mRNAs and a second pathway that works at short, non-polyadenylated and non-coding transcripts such as snoRNAs.

 

 

 

 

 

TPL_asm2013_SEARCH

91209